Rajangam Kanya — SEC insider filings

SEC reporting owner CIK 1816676. 15 insider filings on record with FilingPulse; latest filed 2026-10-23.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2021-01-12 to 2026-10-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Nkarta, Inc. (NKTX)Chief Medical Officer3—1 leg · 10,000 sh · $372,8005
Senti Biosciences Holdings, Inc. (SNTI)Pres. & Chief Med. & Dev. Off.10—2 legs · 1,479 sh · $6,07413
Turnstone Biologics Corp. (TSBX)Director2——2

Insider filings — Rajangam Kanya

FiledFormIssuerReported transactionsSource
2026-10-234Senti Biosciences Holdings, Inc. (SNTI)Tax withholding (F): 19,953 @ $0EDGAR
2026-03-114Senti Biosciences, Inc. (SNTI)Tax withholding (F): 10,757 @ $0EDGAR
2026-02-034Senti Biosciences, Inc. (SNTI)Tax withholding (F): 1,384 @ $0EDGAR
2025-03-114Senti Biosciences, Inc. (SNTI)Conversion (C): 33,000 @ $2.25 · Conversion (C): 33 (derivative) @ $2,250EDGAR
2025-03-104Senti Biosciences, Inc. (SNTI)Grant/award (A): 78,363 @ $0 · Grant/award (A): 235,088 (derivative) @ $0EDGAR
2025-02-064Senti Biosciences, Inc. (SNTI)Sale (S): 1,297 @ $4.07 · Sale (S): 182 @ $4.37EDGAR
2024-12-104Senti Biosciences, Inc. (SNTI)Grant/award (A): 33 (derivative) @ $2,250 · Grant/award (A): 49,500 (derivative) @ $0EDGAR
2024-07-024Turnstone Biologics Corp. (TSBX)Grant/award (A): 12,770 (derivative) @ $0EDGAR
2024-02-024Senti Biosciences, Inc. (SNTI)Grant/award (A): 101,000 @ $0 · Grant/award (A): 152,000 (derivative) @ $0EDGAR
2023-10-174Turnstone Biologics Corp. (TSBX)Grant/award (A): 8,012 (derivative) @ $0EDGAR
2023-02-024Senti Biosciences, Inc. (SNTI)Grant/award (A): 130,000 (derivative) @ $0EDGAR
2022-07-204Senti Biosciences, Inc. (SNTI)Grant/award (A): 327,750 (derivative) @ $0EDGAR
2022-01-194Nkarta, Inc. (NKTX)Grant/award (A): 12,800 @ $0 · Grant/award (A): 76,800 (derivative) @ $0EDGAR
2021-08-094Nkarta, Inc. (NKTX)Option exercise (M): 10,000 @ $0.41 · Sale (S): 10,000 @ $37.28 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-01-124Nkarta, Inc. (NKTX)Grant/award (A): 52,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816676 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs